LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 332 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,846,000 | -13.9% | 21,694 | +0.1% | 0.01% | -16.7% |
| Q1 2021 | $3,306,000 | +58.6% | 21,683 | +3.4% | 0.01% | +50.0% |
| Q4 2020 | $2,084,000 | +4.1% | 20,960 | -0.1% | 0.01% | -11.1% |
| Q3 2020 | $2,001,000 | -14.6% | 20,991 | +0.2% | 0.01% | -18.2% |
| Q2 2020 | $2,343,000 | +49.3% | 20,944 | -2.9% | 0.01% | +22.2% |
| Q1 2020 | $1,569,000 | -34.2% | 21,571 | -5.7% | 0.01% | -18.2% |
| Q4 2019 | $2,385,000 | -3.0% | 22,869 | -7.5% | 0.01% | -8.3% |
| Q3 2019 | $2,460,000 | -15.5% | 24,712 | -3.1% | 0.01% | -14.3% |
| Q2 2019 | $2,910,000 | -13.0% | 25,495 | -4.2% | 0.01% | -12.5% |
| Q1 2019 | $3,346,000 | -10.5% | 26,615 | -3.4% | 0.02% | -23.8% |
| Q4 2018 | $3,739,000 | – | 27,555 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |